| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/14/1998 | EP0817859A1 Novel recombinant dna vectors for gene therapy |
| 01/14/1998 | EP0817858A1 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy |
| 01/14/1998 | EP0817851A2 Dna encoding human papilloma virus type 18 |
| 01/14/1998 | EP0817848A1 In vivo generation of antibodies against antigens secreted in a host by transfected mel cells |
| 01/14/1998 | EP0817847A1 Il-17 receptor |
| 01/14/1998 | EP0817845A1 Conditional expression system |
| 01/14/1998 | EP0817844A1 T-cell receptors and their use in therapeutic and diagnostic methods |
| 01/14/1998 | EP0817800A1 Human g-protein coupled receptors |
| 01/14/1998 | EP0817798A1 Nucleotide and protein sequences of lats genes and methods based thereon |
| 01/14/1998 | EP0817791A1 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis |
| 01/14/1998 | EP0817644A1 Treatment of papillomavirus-associated lesions using interleukin-12 |
| 01/14/1998 | EP0661987B1 Morphogen-induced liver regeneration |
| 01/14/1998 | EP0652890B1 Oligonucleotide alkylphosphonothioates |
| 01/14/1998 | EP0500799B1 Particle mediated transformation of animal skin tissue cells |
| 01/14/1998 | CN1170435A Regulation of neural stem cell proliferation |
| 01/14/1998 | CN1170434A In vitro Induction of dopaminergic cells |
| 01/14/1998 | CN1170412A Suger modified nucleosides and their use for synthesis of oligonucleotides |
| 01/14/1998 | CN1170367A Use of 2'-substituted oligonucleotides to down-regulating gene expression |
| 01/13/1998 | US5708157 Secreted proteins and polynucleotides encoding them |
| 01/13/1998 | US5708149 Method for producing purified recombinant Haemophilus influenzae transferrin binding proteins |
| 01/13/1998 | US5708136 Polypetides which bind to human MDM2 |
| 01/13/1998 | US5707969 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/13/1998 | US5707865 Retroviral vectors for expression in embryonic cells |
| 01/13/1998 | US5707864 Dna comprisinf nucleic acid encoding of mutant htlv matrix |
| 01/13/1998 | US5707863 Tumor suppressor gene merlin |
| 01/13/1998 | US5707860 Vehicle for delivery of particles to a sample |
| 01/13/1998 | US5707795 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 01/13/1998 | US5707618 Adenovirus vectors for gene therapy |
| 01/08/1998 | WO1998000554A1 Protease fmh-1, an ice/ced-like protease |
| 01/08/1998 | WO1998000544A2 Growth arrest gene compositions and methods |
| 01/08/1998 | WO1998000543A1 Hepatocyte growth factor receptor agonists and uses thereof |
| 01/08/1998 | WO1998000542A2 Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia |
| 01/08/1998 | WO1998000541A2 Methods for administration of recombinant gene delivery vehicles for treatment of human disease |
| 01/08/1998 | WO1998000537A1 Composition and methods for modulating the length of telomeres |
| 01/08/1998 | WO1998000531A1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation |
| 01/08/1998 | WO1998000524A1 Method for producing recombinant adenovirus |
| 01/08/1998 | WO1998000172A2 Compositions and methods for altering the biodistribution of biological agents |
| 01/08/1998 | WO1998000166A1 Recombinant canine adenovirus (cav) containing exogenous dna |
| 01/08/1998 | WO1998000163A1 INDUCTION OF CTLs SPECIFIC FOR NATURAL ANTIGENS BY CROSS-PRIMING IMMUNIZATION |
| 01/08/1998 | WO1998000110A1 Emulsion formulations for hydrophilic active agents |
| 01/08/1998 | WO1998000014A1 Transformation and genetherapy of cells of the inner ear |
| 01/08/1998 | WO1998000013A1 Enhancement of cancer cell death |
| 01/08/1998 | WO1997041824A3 Antiangiogenic peptides derived from plasminogen |
| 01/08/1998 | WO1997033995A3 Extracellular matrix signalling molecules |
| 01/08/1998 | WO1997026321A3 Recombinant expression of proteins from secretory cell lines |
| 01/08/1998 | DE19625188A1 System zur Herstellung von AAV-Vektoren System for the production of AAV vectors |
| 01/08/1998 | CA2259389A1 Composition and methods for modulating the length of telomeres |
| 01/08/1998 | CA2259337A1 Growth arrest gene compositions and methods |
| 01/08/1998 | CA2258840A1 Induction of ctls specific for natural antigens by cross-priming immunization |
| 01/08/1998 | CA2258286A1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation |
| 01/08/1998 | CA2258158A1 Method for producing recombinant adenovirus |
| 01/07/1998 | EP0816510A1 Process for producing biologically active fused proteins |
| 01/07/1998 | EP0816502A2 Mur A-1, an UDP-N-acetylglucosamine enolpyruvyl-transferase from Streptococcus pneumoniae |
| 01/07/1998 | EP0816497A2 Human requiem polypeptide for apoptosis |
| 01/07/1998 | EP0816487A1 Recombinant human immunodeficiency virus-producing cell |
| 01/07/1998 | EP0816379A2 DNA binding oligomers |
| 01/07/1998 | EP0815252A1 Gene therapy for transplantation and inflammatory or thrombotic conditions |
| 01/07/1998 | EP0815245A1 Bioactive fusion proteins and pre-existing tumor therapy |
| 01/07/1998 | EP0815239A1 Recombinant viruses expressing lecithin-cholesterol acyltransferase, and uses thereof in gene therapy |
| 01/07/1998 | EP0815237A1 Threonyl-trna synthetase of staphylococcus aureus |
| 01/07/1998 | EP0815232A1 Protein production and delivery |
| 01/07/1998 | EP0815231A2 Use of neuronal apoptosis inhibitor protein (naip) |
| 01/07/1998 | EP0815229A2 Rage tumor rejection antigens |
| 01/07/1998 | EP0815228A2 Cellubrevin homologs |
| 01/07/1998 | EP0815222A1 Sperm factor |
| 01/07/1998 | EP0815220A1 Human amine transporter |
| 01/07/1998 | EP0815218A2 Human vegf-specific antisense oligonucleotides |
| 01/07/1998 | EP0815216A2 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof |
| 01/07/1998 | EP0815215A2 An antisense transcript associated to tumor cells having a t(14;18) translocation and oligodeoxynucleotides useful in the diagnosis and treatment of said tumor cells |
| 01/07/1998 | EP0815214A1 Dna molecules, preparation thereof and use thereof in gene therapy |
| 01/07/1998 | EP0815206A1 Cell culture method |
| 01/07/1998 | EP0815205A1 Method for in vitro preconditioning of myoblasts before transplantation |
| 01/07/1998 | EP0815202A1 Human tissue inhibitor of metalloproteinase-4 |
| 01/07/1998 | EP0815137A1 Human g-protein chemokine receptor hdgnr10 |
| 01/07/1998 | EP0815132A1 Leptospiral outer membrane proteins |
| 01/07/1998 | EP0815129A1 Ingap protein involved in pancreatic islet neogenesis |
| 01/07/1998 | EP0815118A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ARE MEMBERS OF THE MAGE-Xp FAMILY AND USES THEREOF |
| 01/07/1998 | EP0815116A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity |
| 01/07/1998 | EP0815115A1 Keratinocyte growth factor-2 |
| 01/07/1998 | EP0814846A1 Gene therapy by secretory gland expression |
| 01/07/1998 | EP0814845A1 Treatment of tumors by transduction with negative selective markers, application of interaction agents and subsequent radiation exposure |
| 01/07/1998 | EP0814838A1 Antigen presenting system and methods for activation of t-cells |
| 01/07/1998 | EP0814832A1 ISOFORMS OF HUMAN INTERLEUKIN-1$g(b) CONVERTING ENZYME AND METHODS OF USING THE SAME |
| 01/07/1998 | EP0814777A1 Stable lipid-comprising drug delivery complexes and methods for their production |
| 01/07/1998 | EP0814661A1 UBIQUITIN CONJUGATING ENZYMES 7, 8 and 9 |
| 01/07/1998 | EP0646171A4 Improved expression of human multidrug resistance genes and improved selection of cells transduced with such genes. |
| 01/07/1998 | CN1169729A Modulators functions of FAS/APOL receptors |
| 01/06/1998 | US5705732 Protection against hyperacute rejection |
| 01/06/1998 | US5705655 Compounds used to produce liposomes useful as carriers for delivering macromolecules intracellularly |
| 01/06/1998 | US5705625 Genetic engineering; medical diagnosis |
| 01/06/1998 | US5705389 Oligonucleotides that inhibit production of α-tumor necrosis factor |
| 01/06/1998 | US5705388 CETP Ribozymes |
| 01/06/1998 | US5705151 Anticarcinogenic agents using liposomes and genetic engineering |
| 12/31/1997 | WO1997049832A2 Method of identifying cytochrome p450 |
| 12/31/1997 | WO1997049827A2 Adenoviral mediated gene transfer in adipocytes and related implants |
| 12/31/1997 | WO1997049824A1 System for the production of aav vectors |
| 12/31/1997 | WO1997049818A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 12/31/1997 | WO1997049817A1 Brain glycogen phosphorylase cancer antigen |
| 12/31/1997 | WO1997049815A1 Retinoid metabolizing protein |
| 12/31/1997 | WO1997049807A2 A NOVEL HYPERTENSION RELATED CALCIUM REGULATED GENE (HCaRG) |